Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: Insights from the imagine study

European Heart Journal

Volumn 29, Issue 5, 2008, Pages 673-679

  Chocron, Sidney ^a   Baillot, Richard ^b   Rouleau, Jean Lucien ^c   Warnica, Wayne J ^d   Block, Pierre ^e   Johnstone, David ^f   Myers, Martin G ^g   Calciu, Cristina Dana ^h   Nozza, Anna ^c   Martineau, Pierre ^h   Van Gilst, Wiek H ⁱ  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b UNIVERSITÉ LAVAL   (Canada)

^c MONTREAL HEART INSTITUTE   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^f DALHOUSIE UNIVERSITY   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h PFIZER INC   (United States)

ⁱ UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Angioplasty; Coronary artery bypass; Percutaneous coronary; Transluminal

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; BLOOD VESSEL PROSTHESIS; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; EPIDEMIOLOGY; HEART STROKE VOLUME; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; PROSTHESIS FAILURE; RANDOMIZED CONTROLLED TRIAL; REOPERATION; REPERFUSION INJURY; STENT;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS; CORONARY ARTERY BYPASS; CORONARY DISEASE; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; PROSTHESIS FAILURE; REOPERATION; STENTS; STROKE VOLUME; TREATMENT OUTCOME;

EID: 48049093321     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn026     Document Type: Article

References (14)

1. Mercado N, Wijns W, Serruys PW, Sigwart U, Flather MD, Stables RH, O'Neill WW, Rodriguez A, Lemos PA, Hueb WA, Gersh BJ, Booth J, Boersma E. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg 2005;130:512-519.
2. Hoffman SN, TenBrook JA Jr, Wolf MP, Pauker SG, Salem DN, Wong JB. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one-to eight-year outcomes. J Am Coll Cardiol 2003;41:1293-1304.
3. van Domburg RT, Foley DP, de Jaegere PT, de Feyter P, van den Brand M, van der Giessen W, Hamburger J, Serruys PW. Long term outcome after coronary stent implantation: a 10 year single centre experience of 1000 patients. Heart 1999;82:27-34.
4. Kettelkamp R, House J, Garg M, Stuart RS, Grantham A, Spertus J. Using the risk of restenosis as a guide to triaging patients between surgical and percutaneous coronary revascularization. Circulation 2004;110(Suppl. 1):II50-II54.
5. Warnica WJ, Van Gilst WH, Baillot R, Johnstone D, Block P, Myers MG, Chocron S, Ave SD, Martineau P, Rouleau JL. Ischemia management with accupril post bypass graft via inhibition of angio-tensin converting enzyme (IMAGINE): a multi-center randomized trial-design and rationale. Can J Cardiol 2002;18:1191-2000.
6. Rouleau JL, Warnica WJ, Baillot R, Block P, Chocron S, Johnstone D, Myers MG, Calciu CD, Dalle-Ave S, Martineau P, Mormont C, Patni R, Van Gilst WH. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. Circulation 2008;117:24-31.
7. D'Agostino Ralph B Jr. Tutorial in Biostatistics propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statist Med 1998;17:2265-2281.
8. Haase J, Jung T, Störger H, Hofmann M, Reinemer H, Schwarz CE, Schöpf J, Schwarz F. Long-term outcome after implantation of bare metal stents for the treatment of coronary artery disease: rationale for the clinical use of antiproliferative stent coatings. J Interv Cardiol 2003;16:469-473.
9. Johnson RG, Sirois C, Thurer RL, Sellke FW, Cohn WE, Kuntz RE, Weintraub RM. Predictors of CABG within one year of successful PTCA: a retrospective, case-control study. Ann Thorac Surg 1997; 64:3-7.
10. Bourassa MG, Yeh W, Holubkov R, Sopko G, Detre KM. Long-term outcome of patients with incomplete vs complete revascular-ization after multivessel PTCA. A report from the NHLBI PTCA Registry. Eur Heart J 1998;19:103-111.
11. Hassan A, Buth KJ, Baskett RJF, Ali IS, Maitland A, Sullivan JAP, Ghali WA, Hirsch GM. The association between prior percutaneous coronary intervention and short-term outcomes after coronary artery bypass grafting. Am Heart J 2005;150:1026-1031.
12. Kalaycioglu S, Sinci V, Oktar L. Coronary artery bypass grafting (CABG) after successful percutaneous transluminal coronary angioplasty (PCI): is PCI a risk for CABG? Int Surg 1998;83: 190-193.
13. Thielmann M, Neuhäuser N, Knipp S, Kottenberg-Assenmacher E, Marr A, Pizanis N, Hartmann M, Kamler M, Massoudy P, Jakob H. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 2007;134:470-476.
14. Zhao XQ, Kosinski AS, Barnhar HXt, Superko HR, King SB. Prediction of native coronary artery disease progression following PTCA or CABG in the emory angioplasty versus surgery trial. Med Sci Monit 2003;9:CR48-54.